NR4A1 and cancer: Moreover, within hormone receptor-positive (HR+) cancers, these women often exhibit tumors of a higher grade, and young women under the age of 40 with HR+ cancers face a risk of death that is nearly 1.5 to 2 times greater than women over 40 [4,5,8,9,10].